Atlas Trials

Biodistribution Study of CMD-193 in Patients With Advanced Tumours Expressing the Lewis-Y Antigen

Clinical trial NCT00293215 · TERMINATED

Trial details

NCT number
NCT00293215
Sponsor
Ludwig Institute for Cancer Research
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Neoplasms
Start date
2006-02-01
Primary completion
2007-05-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.